qs_id,statement_number,statement
QS112,1,Parents and carers attending postnatal appointments are given information about gastro‑oesophageal reflux (GOR) in infants.
QS112,2,Breast‑fed infants with frequent regurgitation associated with marked distress have their feeding assessed.
QS112,3,Formula‑fed infants with frequent regurgitation associated with marked distress have their symptoms managed using a stepped‑care approach.
QS112,4,Infants with frequent regurgitation associated with marked distress have a trial of alginate therapy if first‑line management is unsuccessful.
QS112,5,Infants and children are not investigated or treated for gastro‑oesophageal reflux disease (GORD) if they have no visible regurgitation and only 1 associated symptom.
QS112,6,Infants and children are not prescribed acid‑suppressing drugs if visible regurgitation is an isolated symptom.
QS112,7,"Infants, children and young people do not have an upper gastrointestinal (GI) contrast study to diagnose or assess the severity of gastro‑oesophageal reflux disease (GORD)."
QS112,8,"Infants, children and young people are not prescribed domperidone, metoclopramide or erythromycin to manage gastro‑oesophageal reflux (GOR) or gastro‑oesophageal reflux disease (GORD) without specialist paediatric advice."
QS112,9,"Infants, children and young people with vomiting or regurgitation and any 'red flag' symptoms are referred to specialist care with investigations as appropriate."
